Financial Performance - The company's revenue for the three months ended June 30, 2025, was $540747 thousand, compared to $340778 thousand for the same period in 2024[194] - Gross profit for the three months ended June 30, 2025, was $47861 thousand, compared to $31868 thousand for the same period in 2024[194] - Net income attributable to the owners of the company for the three months ended June 30, 2025, was $1512 thousand, compared to a net loss of $1215 thousand for the same period in 2024[194] - Adjusted EBITDA for the Q2 2025 was $20043 thousand[199] Agent Network and Transactions - The company has grown agent count by over 7x since the end of 2021[26, 69] - Total agents reached 28034 by Q2 2025[109] - Closed transaction sides reached 49282 in Q2 2025[208] Operational Efficiency - Agent-to-full time brokerage employee ratio was 87:1 in Q2 2025[65] - Adjusted operating expenses have declined from 74% to 50% over the past two years[65] Agent Incentives and Technology - Agents receive 85% of gross commissions before reaching an annual cap of $12000 in the US and CAD $15000 in Canada[41, 130] - Real Wallet generated $247K in revenue in Q2 2025 and was used by ~3600 Real agents as of July 2025[76] Market Outlook - Real's Agent Optimism Index increased to 595 in June from 570 in May, with 38% of agents feeling more optimistic[164] - In June 2025, 48% of agents indicated their local market favored buyers[169]

Company Overview and Strategy - Americold is a global leader in the cold storage industry, operating a network of strategically located warehouses [7, 83] - The company's strategy focuses on solutions, operational excellence, and experienced leadership [7, 83] - Americold has a capital allocation strategy supported by a blue-chip customer base and unique partnerships [7, 83] Financial Performance and Highlights - The company's total enterprise value is $8.7 billion, with an equity market capitalization of $4.8 billion as of June 30, 2025 [13] - LTM Pro Forma Core EBITDA is $626 million [13] - The company experienced a (1.5)% change in total same-store revenue and a (4.2)% change in same-store NOI for Q2 2025 [13] - Adjusted FFO grew by 34% from $299 million in 2021 to $405 million in LTM Q2 25 [15] Infrastructure and Operations - Americold operates approximately 237 warehouses globally, with a total capacity of approximately 1.5 billion cubic feet [11] - The company has a development pipeline of approximately $1 billion in current projects [18, 49] - Americold's operating system (AOS) ensures best practices across the entire warehouse network [18, 52] Growth Drivers and Market Position - The company has strong same-store warehouse revenue and NOI growth [63, 64] - Americold is a global leader in a highly fragmented market, holding 18% of the North American market share and 6% of the global market share [58, 59]

Financial Performance - RXO reported Q2 2025 adjusted EBITDA of $38 million[13] compared to $28 million in Q2 2024[12] - Q2 2025 revenue increased to $1419 million[12] from $930 million in Q2 2024[12], while gross margin was $252 million[12] compared to $177 million[12] - RXO reported Q2 2025 adjusted diluted EPS of $004[24], compared to $003 in Q2 2024[23] - Q2 adjusted free cash flow conversion was 58%[28], and the company remains confident in long-term conversion of 40%-60% across market cycles[29] Operational Highlights - LTL volume increased 45% year-over-year, representing 32% of the total volume[19] - Last Mile stop growth was 17% year-over-year, with a gross margin of 228%[19] - Truckload revenue per load increased 3% year-over-year, and the company expects 2025 contract rates to be up year-over-year[32] - Truckload gross profit per load increased by 7% sequentially in Q2[39] Technology and Integration - ERP consolidation was successfully completed during the second quarter[22] - Customer migration has already begun, and technology integration is anticipated to be substantially complete by the end of Q3[22] Outlook - RXO anticipates Q3 2025 adjusted EBITDA to be between $33 million and $43 million[48] - The company expects brokerage volume to be approximately flat year-over-year and brokerage gross margin to be between 135% and 150%[48]

Financial Highlights - Super Group achieved a record Total Group Revenue of $579 million, a 30% year-over-year increase[13] - The Group's Adjusted EBITDA reached a record $157 million, representing a 78% year-over-year growth and a 27% margin[13] - The company has a debt-free balance sheet with $393 million in unrestricted cash as of June 30, 2025[13,15] - Dividends of $20 million were paid out during the quarter, with a total of $166 million in dividends paid on a trailing twelve-month basis[13] Business Performance - The average unique monthly active customers increased by 21% year-over-year[15] - Net Revenue increased by 30% year-over-year to $570 million[21] - Ex-U S Total Revenue increased 28% year-over-year to $563 million[15,35] - Sportsbook Gross Revenue increased 27% year-over-year, with a margin of 13 9% compared to 12 6% in the same quarter of the previous year[27] - Casino Gross Revenue increased 25% year-over-year, with a margin of 4 44% compared to 4 40% in the same quarter of the previous year[30] Strategic Decisions - Super Group announced a strategic exit from the U S iGaming business[13,49] - The exit from the U S iGaming business will incur one-off costs, including $63 9 million for goodwill and asset impairment, $22 6 million for onerous contracts, and approximately $6 million in cash closing costs[50] Guidance - Ex-U S Adjusted EBITDA guidance was raised from $480 million to a range of $500-$510 million[13] - The company projects total revenue to be greater than $2 04 billion and Adjusted EBITDA to be in the range of $470-$480 million[61]

THE ESSENTIAL REIT Crombie REIT Investor Presentation Q2 2025 COPYRIGHT © CROMBIE REIT OR ITS LICENSORS. ALL RIGHTS RESERVED 2025 Cautionary Statements Forward-looking Information This presentation contains forward-looking statements that reflect the current expectations of management of Crombie about Crombie's future results, performance, achievements, prospects and opportunities. Wherever possible, words such as "continue", "may", "will", "estimate", "anticipate", "believe", "expect", "intend" and similar ...

Company Overview - GoHealth is a leading health insurance marketplace providing personalized guidance to Medicare-eligible consumers[12] - GoHealth has assisted over 11 million consumers with Medicare plan options[15] - The Medicare market is large and growing, with over 68 million eligible lives and over 11,000 new members each day[18] Business Model and Technology - GoHealth utilizes a consumer-centric approach and streamlined Encompass operating model[22] - The company's PlanFit technology platform optimizes enrollment and ensures the best outcomes for consumers[14] - GoHealth's differentiated operating model results in industry-leading customer acquisition costs, with Direct Operating Cost per Submission at $578 in FY24[51, 52] Market Position and Growth - GoHealth is ranked 1 Medicare enroller for health plans[25] - The company projects over 40 million Medicare Advantage enrollees by 2030[55] Competitive Advantage - GoHealth's Direct Operating Cost per Submission is 17% to 31% lower than peers in FY24[51]

Company Transition and Focus - Whitehawk Therapeutics relaunched in March 2025, marking a transition into an ADC-focused company[6] - The company's strategy involves advancing a portfolio of ADC assets rapidly towards clinical trials[7, 9] - Whitehawk anticipates filing INDs for all three assets by mid-2026[9] ADC Technology Platform - Whitehawk utilizes an advanced ADC technology platform engineered for minimal off-target toxicity, greater stability, and a higher therapeutic index[9, 12] - The platform incorporates a proprietary TOPO1 inhibitor payload and a highly stable, cleavable linker[13] - The goal is to improve the therapeutic index compared to first-generation ADCs[14, 15] ADC Programs and Targets - HWK-007 targets PTK7, an oncofetal pseudokinase overexpressed in various tumors, including NSCLC (~63K US metastatic cases annually) and ovarian cancer (~4K)[11, 18] - HWK-016 targets MUC16, a glycoprotein overexpressed in cancers affecting women, such as ovarian (~4K), endometrial, and cervical cancers[11, 18] - HWK-206 targets SEZ6, a CNS protein upregulated in tumors of neuroendocrine origin, including SCLC (~18K) and neuroendocrine tumors (~5K)[11, 18] Financial and Strategic Positioning - Whitehawk's cash runway is expected to fund operations into 2028, including anticipated key clinical data[20]

Company Overview - Jamf defines Apple in the enterprise, serving customers in over 100 countries[17, 21] - The company boasts a No 1 market position with a 23% CAGR since its 2020 IPO[18] - Jamf's net retention rate is strong at 103%[18] - Subscription revenue accounts for 98% of the total[18] Market Opportunity and Growth - The total addressable market (TAM) is estimated at approximately $49 billion, with a serviceable addressable market (SAM) of around $21.7 billion[48] - Jamf's current market share of the SAM is about 3%, representing $646 million[48] - The total SAM is projected to grow to roughly $27 billion by 2026[52] - There's a significant security cross-sell opportunity within the existing customer base, estimated at around $350 million[71] Financial Performance - In FY2024, Jamf's annual recurring revenue (ARR) reached $646 million[51] - Non-GAAP operating income for FY2024 was $103 million, resulting in a 16% margin[84] - The company has consistently met or exceeded expectations every quarter since its IPO[35]

Financial Performance - H1 net fee income increased by 0.1% year-on-year on a constant currency like-for-like basis[10] - Q2 net fee income grew by 2.0% year-on-year (CC LFL), offsetting a 1.9% reduction in Q1 (CC LFL)[10] - Adjusted operating profit increased by 55% (CC LFL), with a reported increase of 70% to £1.7 million[10] - Reported net fee income decreased by 8% to £23.4 million, reflecting 2024 exits and FX movements[10] - Net debt increased to £16.1 million, up from £15.3 million at the end of 2024, driven by foreign exchange movements[10] Regional Performance - US net fee income increased by 38% (CC LFL)[10] - Offshore Services net fee income increased by 11% (CC LFL)[10] - UK net fee income decreased by 9%[10] Core vs Non-Core Operations - Adjusted operating profit for core operations increased by 86%[14] - Adjusted operating profit for non-core operations decreased by 32%[14] Strategic Initiatives - Prioritized investment in the US and UK, including sales training[11] - Brand transformation is on track for end-of-year launch[11] - Progressing well with non-core asset divestment, with active processes and discussions[11]

Azimut Group IR Presentation August 2025 Azimut Group – IR Presentation Table of Contents About Azimut 3 Total Assets 12 Business update 19 Financials 31 2025 Guidance 45 2 2 Azimut Group At a glance Azimut is an independent global firm specializing in asset management across public and private markets, wealth management, investment banking, and fintech, serving private and corporate clients in 20 countries € 113bn Total Assets 230+ investment professionals ~900 employees globally 1.4m+ investors globally1 ...